Clinical Trials · NCT05746039
Feasibility of Semaglutide in Advanced Lung Disease
- Phase
- Phase 1/Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Pennsylvania
- Enrollment
- 8
- Start date
- Jan 2024
- Locations
- 1 site, United States
- Primary endpoint
- Tolerability